SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.

SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself.
复制标题

DOI:
10.1038/s41467-021-22210-3
复制
发表时间:
2021-03-30
影响因子:
16.6
通讯作者:
Mashreghi MF
Mashreghi MF
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Ferreira-Gomes M;Kruglov A;Durek P;Heinrich F;Tizian C;Heinz GA;Pascual-Reguant A;Du W;Mothes R;Fan C;Frischbutter S;Habenicht K;Budzinski L;Ninnemann J;Jani PK;Guerra GM;Lehmann K;Matz M;Ostendorf L;Heiberger L;Chang HD;Bauherr S;Maurer M;Schönrich G;Raftery M;Kallinich T;Mall MA;Angermair S;Treskatsch S;Dörner T;Corman VM;Diefenbach A;Volk HD;Elezkurtaj S;Winkler TH;Dong J;Hauser AE;Radbruch H;Witkowski M;Melchers F;Radbruch A;Mashreghi MF

文献摘要

参考文献

被引文献

相似文献

严重COVID-19的发病机制反映了对SARS-CoV-2的免疫反应效率低下。在这里,我们在单细胞水平上分析了流出到血液中的浆母细胞,以研究需要重症监护的COVID-19患者的适应性免疫反应的动态。在对SARS-CoV-2刺突蛋白应答的血清转化之前,外周浆母细胞显示1型干扰素诱导的基因表达特征;然而,在血清转化之后,浆母细胞失去该特征,而是表达由IL-21和TGF-β诱导的基因特征,并且主要产生IgG 1和IgA 1。在COVID-19患者的持续免疫反应中,浆母细胞转向表达IgA 2,从而反映了TGF-β的指示。尽管浆母细胞继续存在于血液中,但在死亡的COVID-19患者的肺部中未发现浆母细胞,患者IgA 2也不与SARS-CoV-2的优势抗原结合。因此,我们的研究结果表明,在严重的COVID-19中,SARS-CoV-2触发了一种由TGF-β指导的慢性免疫反应,并分散了自身的注意力。目前对SARS-CoV-2诱导的体液免疫机制的认识尚不清楚。在这里,作者分析了单细胞水平的B细胞反应,发现在严重的COVID-19患者中,浆母细胞从IFN转变为TGFβ指令,以产生对主要SARS-CoV-2抗原不特异的伊加抗体。
The pathogenesis of severe COVID-19 reflects an inefficient immune reaction to SARS-CoV-2. Here we analyze, at the single cell level, plasmablasts egressed into the blood to study the dynamics of adaptive immune response in COVID-19 patients requiring intensive care. Before seroconversion in response to SARS-CoV-2 spike protein, peripheral plasmablasts display a type 1 interferon-induced gene expression signature; however, following seroconversion, plasmablasts lose this signature, express instead gene signatures induced by IL-21 and TGF-β, and produce mostly IgG1 and IgA1. In the sustained immune reaction from COVID-19 patients, plasmablasts shift to the expression of IgA2, thereby reflecting an instruction by TGF-β. Despite their continued presence in the blood, plasmablasts are not found in the lungs of deceased COVID-19 patients, nor does patient IgA2 binds to the dominant antigens of SARS-CoV-2. Our results thus suggest that, in severe COVID-19, SARS-CoV-2 triggers a chronic immune reaction that is instructed by TGF-β, and is distracted from itself. Our understanding on the humoral immunity induced by SARS-CoV-2 is still lacking. Here the authors analyze B cell responses at the single cell level to find that, in severe COVID-19 patients, plasmablasts shift from IFN to TGFβ instruction to produce IgA antibodies that are not specific to dominant SARS-CoV-2 antigens.
DOI: 10.1038/nbt.4314
发表时间: 2019-01-01
影响因子: 46.9
作者:
Becht, Etienne;McInnes, Leland;Newell, Evan W.
通讯作者: Newell, Evan W.
DOI: 10.1186/s42358-020-00151-7
发表时间: 2020-09-22
期刊: Advances in rheumatology (London, England)
影响因子: --
作者:
Bordallo B;Bellas M;Cortez AF;Vieira M;Pinheiro M
通讯作者: Pinheiro M
DOI: 10.1093/intimm/3.11.1099
发表时间: 1991-11-01
影响因子: 4.4
作者:
ISLAM, KB;NILSSON, L;SMITH, CIE
通讯作者: SMITH, CIE
DOI: 10.1002/path.2067
发表时间: 2006-11-01
影响因子: 7.3
作者:
He, L.;Ding, Y.;Jiang, S.
通讯作者: Jiang, S.
DOI: 10.1038/ncomms10875
发表时间: 2016-02-26
影响因子: 16.6
作者:
Vu Van D;Beier KC;Pietzke LJ;Al Baz MS;Feist RK;Gurka S;Hamelmann E;Kroczek RA;Hutloff A
通讯作者: Hutloff A